February 11, 2022
Gehrig named Chair of UVA Department of Obstetrics and Gynecology
Paola A. Gehrig, MD, will begin her new role on June 27. She completed her residency in obstetrics and gynecology at the University of Virginia.
Category: Cancer
January 26, 2022
Ground-Breaking Study Reveals Dynamics of DNA Replication ‘Licensing’
This research, led by Jean Cook, PhD, and Liu Mei, PhD, at the UNC School of Medicine, may help explain why certain parts of the genome become highly mutable in some cancers.
January 25, 2022
Donor Gives $25 million to Establish UNC Lineberger Center for Triple Negative Breast Cancer
The record-setting gift supports development of innovative cancer treatments, eradicating health disparities. The center's inaugural director is Lisa Carey, PhD, the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research.
January 20, 2022
UNC Medical Center Receives NAPRC Accreditation
The UNC Medical Center is the only organization in North Carolina accredited by the Commission on Cancer’s National Accreditation Program for Rectal Cancer.
December 23, 2021
Ting Receives Illinois State University Distinguished Alumni Award
Jenny Ting, PhD, is the recipient of the Illinois State University Distinguished Alumni Award for her outstanding immunology research.
December 15, 2021
Reminder: Eshelman Institute Grant Funding Available
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
October 6, 2021
$1 Million gift furthers landmark study focused on reducing breast cancer disparities, barriers to high quality care
Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina, have donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study.
September 29, 2021
Mungo Appointed as Women’s Reproductive Health Research Scholar
Chemtai Mungo, MD, MPH, has been appointed as a UNC WRHR Scholar. Her primary research is focused on increasing access to cervical cancer prevention in low-income countries.
September 23, 2021
Therapy Using Dual Immune System Cells Effectively Controls Neuroblastoma
Hongwei Du, PhD, and Gianpietro Dotti, MD, published research in Nature Cancer showing that a dual-threat CAR-T immunotherapy was effective in animal models of neuroblastoma, a nerve cell cancer.
September 14, 2021
UNC Lineberger Developmental Funding Program: Fall Application Cycle Now Open
The UNC Lineberger Developmental Funding Program supports the development of cancer research led by faculty to stimulate new applications for extramural funding. All UNC Lineberger Comprehensive Cancer Center members, UNC-Chapel Hill faculty, and UNC system school faculty are encouraged to apply. Available targeted RFAs for the Fall 2021 cycle: (1) Cancer Survivorship Research, (2) Cancer Screening, (3) Population Sciences Approach to Addressing Cancer Disparities in North Carolina
August 4, 2021
Poteat, Colleagues Publish Breast Cancer Care Research
Tonia Poteat, PhD, MPH, a core member of the Center for Health Equity Research, and colleagues published research on delays in breast cancer care by race and sexual orientation.
July 12, 2021
Carey Featured in Video on Clinical Implications of the FeDeriCa trial in HER2+ Breast Cancer
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.